Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00916435 · ClinicalTrials.gov registry record
Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 630
- Enrollment target
NCT00916435: Completed study, sponsored by Johns Hopkins University.
NCT00916435 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 630 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00916435 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 630 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used: * to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and * to predict progression of heart failure in patients with ICD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00916435
The ClinicalTrials.gov registry entry for NCT00916435 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 630 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00916435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00916435 about?
NCT00916435 is a clinical study titled "Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms". The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used: * to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and * to predict progression of heart failure in patients with ICD.
What is the current status of trial NCT00916435?
This trial is currently completed. The enrollment target is 630 participants. The study started on 2005-03. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00916435?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.